CN100345974C - Microbiological preparation method of S-(+)-2,2-dimethyl cyclo propyl formamide - Google Patents
Microbiological preparation method of S-(+)-2,2-dimethyl cyclo propyl formamide Download PDFInfo
- Publication number
- CN100345974C CN100345974C CNB2005100616809A CN200510061680A CN100345974C CN 100345974 C CN100345974 C CN 100345974C CN B2005100616809 A CNB2005100616809 A CN B2005100616809A CN 200510061680 A CN200510061680 A CN 200510061680A CN 100345974 C CN100345974 C CN 100345974C
- Authority
- CN
- China
- Prior art keywords
- cctcc
- dimethyl cyclopropane
- dimethylcyclopropanecarboxamide
- racemic
- buffer solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 8
- 230000002906 microbiologic effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 14
- RCNSYWXQFUUPBG-UHFFFAOYSA-N 1,1-dimethylcyclopropane;formamide Chemical compound NC=O.CC1(C)CC1 RCNSYWXQFUUPBG-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241001051769 Delftia tsuruhatensis Species 0.000 claims abstract description 7
- 241000316848 Rhodococcus <scale insect> Species 0.000 claims abstract description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 34
- 239000001963 growth medium Substances 0.000 claims description 32
- 239000000243 solution Substances 0.000 claims description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 27
- CZPCJHBAFHCDRE-UHFFFAOYSA-N 2,2-dimethylcyclopropane-1-carbonitrile Chemical compound CC1(C)CC1C#N CZPCJHBAFHCDRE-UHFFFAOYSA-N 0.000 claims description 26
- 238000000855 fermentation Methods 0.000 claims description 26
- 230000004151 fermentation Effects 0.000 claims description 26
- YBZQRYWKYBZZNT-UHFFFAOYSA-N 2,2-dimethylcyclopropane-1-carboxamide Chemical compound CC1(C)CC1C(N)=O YBZQRYWKYBZZNT-UHFFFAOYSA-N 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 244000005700 microbiome Species 0.000 claims description 23
- 239000007853 buffer solution Substances 0.000 claims description 21
- 239000007836 KH2PO4 Substances 0.000 claims description 20
- 239000001888 Peptone Substances 0.000 claims description 20
- 108010080698 Peptones Proteins 0.000 claims description 20
- 239000001110 calcium chloride Substances 0.000 claims description 20
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 20
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 claims description 20
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 20
- 235000019319 peptone Nutrition 0.000 claims description 20
- 239000000758 substrate Substances 0.000 claims description 20
- 239000002609 medium Substances 0.000 claims description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- RSYOSUMAMNFKSM-UHFFFAOYSA-N 2-[(7-chloroquinolin-4-yl)amino]ethanol Chemical compound ClC1=CC=C2C(NCCO)=CC=NC2=C1 RSYOSUMAMNFKSM-UHFFFAOYSA-N 0.000 claims description 17
- 241001052560 Thallis Species 0.000 claims description 17
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 17
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 17
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 17
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 17
- 239000011780 sodium chloride Substances 0.000 claims description 17
- 229940041514 candida albicans extract Drugs 0.000 claims description 16
- 238000012258 culturing Methods 0.000 claims description 16
- 239000012138 yeast extract Substances 0.000 claims description 16
- 230000006698 induction Effects 0.000 claims description 15
- 239000002504 physiological saline solution Substances 0.000 claims description 15
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 241000158504 Rhodococcus hoagii Species 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 239000000411 inducer Substances 0.000 claims description 12
- 238000011218 seed culture Methods 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 239000012190 activator Substances 0.000 claims description 9
- 239000002689 soil Substances 0.000 claims description 9
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 8
- 229930195725 Mannitol Natural products 0.000 claims description 8
- 239000000594 mannitol Substances 0.000 claims description 8
- 235000010355 mannitol Nutrition 0.000 claims description 8
- 241001600129 Delftia Species 0.000 claims description 7
- 230000036983 biotransformation Effects 0.000 claims description 7
- 239000008399 tap water Substances 0.000 claims description 7
- 235000020679 tap water Nutrition 0.000 claims description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 6
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 6
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 claims description 5
- 230000001131 transforming effect Effects 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 239000008055 phosphate buffer solution Substances 0.000 claims description 4
- 239000010865 sewage Substances 0.000 claims description 4
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 abstract 3
- QTOIEJQXVZRGBZ-UHFFFAOYSA-N 1,1-dimethylcyclopropane formonitrile Chemical compound C#N.CC1(CC1)C QTOIEJQXVZRGBZ-UHFFFAOYSA-N 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229960001031 glucose Drugs 0.000 description 10
- 230000001954 sterilising effect Effects 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 108700023418 Amidases Proteins 0.000 description 5
- 108010024026 Nitrile hydratase Proteins 0.000 description 5
- 102000005922 amidase Human genes 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- -1 Nitrile compounds Chemical class 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- YBZQRYWKYBZZNT-BYPYZUCNSA-N (1r)-2,2-dimethylcyclopropane-1-carboxamide Chemical compound CC1(C)C[C@H]1C(N)=O YBZQRYWKYBZZNT-BYPYZUCNSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- JWEFQVVDPVVSGR-UHFFFAOYSA-J carbanide;cyclopenta-1,3-diene;tantalum;tetrachloride Chemical compound [CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[Cl-].[Cl-].[Cl-].[Cl-].[Ta].C1C=CC=[C-]1 JWEFQVVDPVVSGR-UHFFFAOYSA-J 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000003912 environmental pollution Methods 0.000 description 3
- 229910052564 epsomite Inorganic materials 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 229910052603 melanterite Inorganic materials 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- BFNMOMYTTGHNGJ-UHFFFAOYSA-N 2,2-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1(C)CC1C(O)=O BFNMOMYTTGHNGJ-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- DHSUYTOATWAVLW-WFVMDLQDSA-N cilastatin Chemical compound CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O DHSUYTOATWAVLW-WFVMDLQDSA-N 0.000 description 2
- 229960004912 cilastatin Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N imipenem Chemical compound C1C(SCC\N=C\N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 description 2
- 229960002182 imipenem Drugs 0.000 description 2
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZWECSSDPWNBWLT-UHFFFAOYSA-N 1,2-dimethylcyclopropane-1-carbonitrile Chemical group CC1CC1(C)C#N ZWECSSDPWNBWLT-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FJZDFUMWGKQMMT-UHFFFAOYSA-N 2,3-dimethylcyclopropane-1-carbonitrile Chemical compound CC1C(C1C)C#N FJZDFUMWGKQMMT-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- IJFXRHURBJZNAO-UHFFFAOYSA-M 3-hydroxybenzoate Chemical compound OC1=CC=CC(C([O-])=O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-M 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 1
- IZSRJDGCGRAUAR-MROZADKFSA-M 5-dehydro-D-gluconate Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IZSRJDGCGRAUAR-MROZADKFSA-M 0.000 description 1
- UCDBLYHPJMMFMY-UHFFFAOYSA-N 8-bromoquinoline-4-carbonitrile Chemical compound C1=CN=C2C(Br)=CC=CC2=C1C#N UCDBLYHPJMMFMY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 101710180684 Beta-hexosaminidase Proteins 0.000 description 1
- 101710124976 Beta-hexosaminidase A Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000589519 Comamonas Species 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 108010033272 Nitrilase Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 102100030122 Protein O-GlcNAcase Human genes 0.000 description 1
- 101710081801 Protein O-GlcNAcase Proteins 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 101710199095 Putative beta-hexosaminidase Proteins 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- 241000608953 Rhodococcus sp. AJ270 Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000287433 Turdus Species 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 238000004176 ammonification Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- DLRVVLDZNNYCBX-ABXHMFFYSA-N melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-ABXHMFFYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- UKXAGBYRVKMKEA-UHFFFAOYSA-N phosphoric acid trihydrochloride Chemical compound Cl.Cl.Cl.P(O)(O)(O)=O UKXAGBYRVKMKEA-UHFFFAOYSA-N 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- CQRYARSYNCAZFO-UHFFFAOYSA-N salicyl alcohol Chemical compound OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- TYFQFVWCELRYAO-UHFFFAOYSA-L suberate(2-) Chemical compound [O-]C(=O)CCCCCCC([O-])=O TYFQFVWCELRYAO-UHFFFAOYSA-L 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 241001624918 unidentified bacterium Species 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention discloses a new method for preparing a microbe of S-(+)-2, 2-dimethyl cyclopropane formamide. The present invention includes a method for producing racemic 2, 2-dimethyl cyclopropane formamide by using a new microbe of Rhodococcuss equi CCTCC No. M205114 to catalyze racemic 2, 2-dimethyl cyclopropane formonitrile and a method for producing S-(+)-2, 2-dimethyl cyclopropane formamide by using a new microbe of Delftia tsuruhatensis CCTCC No. M205115 to selectively catalyze and hydrolyze racemic 2, 2-dimethyl cyclopropane formamide, or a method for producing the S-(+)-2, 2-dimethyl cyclopropane formamide by using CCTCC No. M205114 and CCTCC No. M205115 to jointly convert the racemic 2, dimethyl cyclopropane formonitrile. The yield of the present invention is over 47%, and an e. e value is more than 98%.
Description
Technical Field
The invention relates to a method for producing racemic 2, 2-dimethylcyclopropanecarboxamide by catalyzing racemic 2, 2-dimethylcyclopropanecarbonitrile with two new microorganisms screened from soil and sewage, and producing S- (+) -2, 2-dimethylcyclopropanecarboxamide by selectively hydrolyzing racemic 2, 2-dimethylcyclopropanecarboxamide.
Background
Nitrile compounds are widely distributed in nature and are also important C1The traditional chemical method for hydrolyzing nitrile substances has large energy consumption, a plurality of byproducts and strong acid or strong base, so that the method is only limited to nitrile compounds without easily hydrolyzable groups and has no selectivity. On the contrary, the conversion of nitrile compounds into corresponding amides and acids by microorganisms has the advantages of mild conditions, little environmental pollution, realization of chemoselectivity, regioselectivity, stereoselectivity, and the like. At present, microorganism-derived nitrile hydratase has been successfully applied to biocatalytic production of acrylamide, nicotinamide, and the like.
The microbial degradation of nitrile substances includes three ways of oxidation, reduction, hydrolysis and the like. The latter can in turn be divided into two classes according to the enzyme systems involved in the hydrolysis reaction: one is nitrilase (e.c. 3.5.5.1), which directly hydrolyzes nitriles to carboxylic acids and ammonia; another approach is to hydrolyze the nitrile to the amide by the action of nitrile hydratase (E.C.4.2.1.84), which, if amidase (E.C.3.5.1.4) is also present in the microorganism, leads to the further formation of carboxylic acid and ammonia, and the reaction is carried out in two steps.
S- (+) -2, 2-dimethylcyclopropanecarboxamide is an important intermediate of cilastatin. Cilastatin, the chemical name of which is (+) - (Z) -7- [ (2R) - (2-amino-2-carboxyethyl) sulfur]-2- [ (1S) - (2, 2-dimethylcyclopropanecarboxamido)]-2-heptenoic acid, is the first kidney dehydropeptidase inhibitor applied to clinical application, can effectively prevent the kidney dehydropeptidase in vivo from degrading imipenem and enhance the antibacterial activity of imipenem.
Robins et al (US Patent 5273903, 5427934) have reported that the synthesis of a compound from racemic 2, 2-dimethylcyclopropanecarboxamide by the optically selective amidase-containing microorganism Comamonas acidovarans a: 18(DSM No.6315), Commonas acidovanansTG 308(DSM No.6552), Pseudomonas sp.NSAK: 42(DSM No.6433), Bacterium sp.VIII: II (DSM No.6316) kinetic resolution, conversion of R- (-) -2, 2-dimethylcyclopropanecarboxamide therein to the corresponding acid to prepare S- (+) -2, 2-dimethylcyclopropanecarboxamide. LIM, Kwang-Min et al reported that racemic 2, 2-dimethylcyclopropanecarboxylic acid was first derivatized to the corresponding ethyl ester, S- (+) -2, 2-dimethylcyclopropanecarboxylic acid ethyl ester therein was selectively hydrolyzed to the corresponding amide and ethanol by an optically selective lipase, and S-amide was prepared by the ammonification of S- (+) -2, 2-dimethylcyclopropanecarboxylic acid (WO 2004/005241A 1).
Mei-xing Wang et al (Journal of Molecular Catalysis B: Enzymatic, 2002, 18: 267-272) have reported the preparation of R- (-) -2, 2-dimethylcyclopropanecarboxamide and S- (+) -2, 2-dimethylcyclopropanecarboxylic acid using racemic 2, 2-dimethylcyclopropanecarbonitrile as a substrate and Rhodococcus sp.AJ270 as a catalyst.
However, reports that racemic 2, 2-dimethylcyclopropanecarbonitrile is taken as a substrate, corresponding amide is prepared by a microbial catalysis method, and then the amide is selectively hydrolyzed to produce S- (+) -2, 2-dimethylcyclopropanecarboxamide are not seen at home and abroad. Starting from the same substances, the amide is prepared by a chemical method through refluxing dimethylcyclopropanecarbonitrile in 6mol/L KOH aqueous solution for 8-16 h. However, this process involves strong alkali and high-temperature and high-pressure reaction conditions, which cause environmental pollution, and the by-product 2, 2-dimethylcyclopropanecarboxylic acid (J.Am.chem.Soc, 1957, 79: 3467-3469) is inevitably produced therein. Therefore, the 2, 2-dimethyl cyclopropane carboxamide is catalytically synthesized by a microbiological method, provides raw materials for further kinetic resolution, and is selectively hydrolyzed, so that the method has economic and social values.
Disclosure of Invention
The present invention provides novel microorganisms selected from soil and sewage that convert racemic 2, 2-dimethylcyclopropanecarbonitrile to the corresponding amides, and novel microorganisms that selectively hydrolyze the amides, respectively. Secondly, a method for producing amides by transformation with the novel microorganism and producing optically active amides by selective hydrolysis is provided.
Relates to the synthesis principle of 2, 2-dimethyl cyclopropane carboxamide and S-2, 2-dimethyl cyclopropane carboxamide, and the reaction formula is as follows:
the microorganism for producing nitrile hydratase provided by the invention isRhodococcus equi (Rhodococcus equi) of Rhodococcus, the strain is preserved in China Center for Type Culture Collection (CCTCC) 10 months and 10 days in 2005, and the preservation number is CCTCC No. M205115.
The new strain is characterized as follows:
colony morphology: culturing at 30 deg.C for 2 days, wherein the colony on beef extract peptone plate is round, has a diameter of 2 mm, and has a convex lens shape, light red color, regular edge, and smooth surface.
Cell morphology: is in the shape of a straight thin rod, 0.3-0.8 μm multiplied by 1.5-8.0 μm; cells appeared as single pairs, no sporulation, no motility.
The strain is characterized by positive catalase, positive nitrate reduction, negative pyrazinamine enzyme, negative pyrrolidone arylamine enzyme, positive alkaline phosphatase, negative β -glucuronidase, negative β -galactosidase, positive α -glucosaccharase, negative N-acetyl- β -glucosaminidase, negative esculetin hydrolysis, negative urease and negative gelatin hydrolysis.
The microorganism for producing the optical selectivity amidase is Delftia tsuruhatensis (Chinese name can not be found) bacteria of Delftia, which is deposited in China center for type culture collection, CCTCC for short, 10 months in 2005 and has the collection number of CCTCC No. M205114.
The new strain is characterized as follows:
colony morphology: culturing at 30 deg.C for 3 days, wherein the colony on beef extract peptone plate is round, has a diameter of 3 mm, and has a tip-shaped bulge, and neat and smooth edge.
Cell morphology: the shape of a slightly bent rod is 1.4-4.0 mu m long and 0.6-1.3 mu m wide, and the rod appears singly or in pairs, does not form spores and can move.
Physiologicaland biochemical characteristics: the new strains screened from the soil are gram negative, arginine double hydrolase positive, oxidase positive, catalase positive, esterase (Tween 80) positive and cytochrome oxidase positive. Glucose produces acid negatively, fructose produces acid positively. Nitrate and nitrite reduction is negative. Rhamnose, N-acetylglucosamine, ribose, inositol, sucrose, glycogen, D-glucose, saligenin, D-melibiose, L-fucose, D-sorbitol, L-arabinose, L-serine, as a carbon source, could not be utilized. Itaconic acid, suberate, malonate, acetate, DL-lactate, L-alanine, 5-keto-gluconate, 3-hydroxy-benzoate, mannitol, propionate, caprate, valerate, citrate, histidine, 3-hydroxy-butyrate, L-proline, terephthalate can be used as a carbon source. Taken together with the above results, this strain was identified as Delftia tsuuhatensis.
The microorganism of the present invention is obtained by screening according to the following procedures:
1) and inoculating the collected soil sample and sewage sample into an enrichment culture medium, culturing for 4 days on a shaking table at 30 ℃ and 150rpm, taking 1ml of culture solution to transfer into a fresh enrichment culture medium after the culture medium becomes turbid, and culturing for 4 days. Repeating the above steps for 4-5 cycles. 1-2.5 g/L of 2, 2-dimethylcyclopropanecarbonitrile (for screening CCTCC No. M205115) or 2, 2-dimethylcyclopropanecarboxamide (for screening CCTCC No. M205114) is used as a unique nitrogen source in the enrichment medium, and the formula of other substances is as follows (g/L): na (Na)2HPO4·12H2O：1.0～2.5，KH2PO4：1.0～2.0，MgSO4·7H2O：0.2～0.5，FeSO4·7H2O：0.01～0.05，CoCl2：0.01～0.05，CaCl2: 0.01-0.06, prepared by tap water, and adjusting the pH value to 6.0-8.0 by using 1.0mol of hydrochloric acid or NaOH solution.
2) And (4) diluting the enrichment culture solution for the last time, coating the enrichment culture solution on a plate culture medium, and selecting a single colony to be stored on an inclined plane. The plate culture medium is an enrichment culture medium added with 1.5 to 2.0 percent of agar.
3) The single colony picked is inoculated to an induction fermentation medium, and the components are as follows (g/L): 10.0-20.0% of glucose, 5.0-10.0% of yeast extract, 2.0-5.0% of peptone, 1.0-3.0% of NaCl and K2HPO41.0～2.0，KH2PO41.0～2.0，MgSO40.2～0.5，FeSO40.01～0.05，CoCl20.01～0.05，CaCl20.05-0.1, caprolactam 1.0-2.0, and natural pH (sterilization for 20min at 121 ℃); culturing for 48-72 h, suspending in a phosphoric acid buffer system after centrifugation, adding 2, 2-dimethylcyclopropanecarbonitrile or amide as a substrate, and converting; the amounts of product and substrate were analyzed by gas chromatography. The specific operating conditions are as follows: the gas chromatograph is GC-14C, the capillary column is HP-1, the temperatures of the injection port, the detector and the column box are respectively 180 ℃, 220 ℃ and 120 ℃, and the split ratio is 50: 1. The contents of R-and S-2, 2-dimethylcyclopropanecarboxamide in the conversion product were determined by chiral liquid chromatography. Firstly, amide is derived into N, N-benzhydryl amide, and is separated on a Chiralcel OD column, wherein the mobile phase is cyclohexane/2-acetone, the ratio is 9: 1, and the flow rate is 0.4 ml/min.
Primary culture: the screened microorganisms are inoculated into a seed culture medium for primary culture. The seed culture medium comprises the following components (g/L): 10.0-20.0% of glucose, 5.0-10.0% of yeast extract, 2.0-5.0% of peptone, 1.0-3.0% of NaCl and K2HPO41.0～2.0，KH2PO41.0～2.0，MgSO40.2～0.5，FeSO40.01～0.05，CoCl20.01～0.05，CaCl20.05-0.1, natural pH (121 deg.C, sterilization)20 min). The requirement of the seed culture medium is to have a proper C/N ratio and to shorten the growth lag phase of the microorganisms as much as possible. Suitable carbon sources are also glycerol, maltose, fructose, sucrose, mannitol, and the like; suitable nitrogen sources are peptone, beef extract, soybean powder, ammonium sulfate, and the like. The pH value of the culture medium is 6-8, and the culture temperature is 20-50 ℃. After culturing in the seed culture medium for 24-48 h, inoculating a fermentation induction culture medium can be prepared.
Induction: since the nitrile hydratase contained in the microorganism of the invention is an inducible enzyme, the enzyme activity is high only after induction. The amidase contained in the microorganism is a constitutive enzyme, induction is not needed, but the enzyme activity can be greatly improved by adding a proper chemical substance as an activator, such as caprolactam, isobutyronitrile, 2-dimethylcyclopropanecarboxamide and the like, wherein the amount of the activator is 1.0-2.0 g/L of the culture medium. Inoculating the seed liquid into an induction culture medium according to a certain proportion, wherein the induction culture medium is generally prepared by adding a proper inducer on the basis of the seed culture medium, the inducer comprises one of 2, 2-dimethylcyclopropanecarbonitrile, 2-dimethylcyclopropanecarboxamide, acrylamide, caprolactam, acetamide and acrylonitrile, and the proper amount of the inducer is 1.0-2.0 g/L of the induction culture medium. After 60-80 h of induction, collecting thalli through centrifugation or filtration, and providing a catalyst for the next step of biotransformation.
And (3) biotransformation: the biotransformation process uses the cells or cell treated matters of the microorganism Rhodococcus equiCCTCC No. M205115 and Delftia tsuuhatensis CCTCC No. M205114 of the present invention as catalysts, and suitable systems for biotransformation include phosphate buffer solution, Tris-hydrochloric acid buffer solution, citric acid buffer solution, etc. The pH range of the buffer system is 6.5-9.0. The temperature range during the conversion is 20-40 ℃. The amount of the substrate in the conversion system is in the range of 0.08-2% (wt/v, weight to volume ratio, the same applies hereinafter), and the optimum range is 0.1-2% (wt/v). The 2, 2-dimethylcyclopropanecarbonitrile can be completely converted into corresponding racemic amide by taking Rhodococcus equi CCTCC No. M205115 cells as a catalyst and reacting for 0.5-4 h. After removing cells by centrifugation, cells of Delftia tsuruhatensis CCTCC No. M205114 were added to the transformation solution, and R- (-) -2, 2-dimethylcyclopropanecarboxamide in the transformation solution was further converted into the corresponding acid to prepare S- (+) -2, 2-dimethylcyclopropanecarboxamide. Because the solubility of the 2, 2-dimethyl cyclopropane formamide in water is low, the conversion solution is subjected to decompression evaporation after being extracted by ethyl acetate, the obtained solid is dissolved in hot methanol and is placed in an ice bath overnight, and the separated crystal is dried in an evaporation dish after being filtered, so that the optically pure S- (+) -2, 2-dimethyl cyclopropane formamide is obtained.
The method takes 2, 2-dimethylcyclopropanecarbonitrile as a substrate, synthesizes the 2, 2-dimethylcyclopropanecarboxamide by a biotransformation method, and has the advantages of mild reaction conditions, simple reaction process, higher yield and less environmental pollution. Meanwhile, newly screened microorganisms are directly added into the conversion solution in the step as a catalyst, and the racemic amide is hydrolyzed in an optical selectivity mode to generate S- (+) -2, 2-dimethyl cyclopropane formamide, so that the extraction steps of intermediate products are reduced, the yield and the corresponding body excess value are high and reach more than 43% and 98% respectively.
Detailed description of the preferred embodiments
The following examples are presented to enable one of ordinary skill in the art to more fully understand the present invention.
Preparing a culture medium:
(1) the composition and the proportioning range of the enrichment medium are as follows (g/L): na (Na)2HPO4·12H2O：1.0～2.5，KH2PO4：1.0～2.0，MgSO4·7H2O：0.2～0.5，FeSO4·7H2O：0.01～0.05，CoCl2：0.01～0.05，CaCl2: 0.01-0.06, 2, 2-dimethylcyclopropanecarbonitrile (screening CCTCC No. M205115) or 2, 2-dimethylcyclopropanecarboxamide (screening CCTCC No. M205114): 1.0-2.5, prepared by tap water, and adjusting the pH value to 6.0-8.0 by using 1.0mol of hydrochloric acid or NaOH solution.
(2) The seed culture medium comprises the following components in percentage by weight and volume, namely g/L: 10.0-20.0% of glucose, fermenting5.0-10.0 of mother extract, 2.0-5.0 of peptone, 1.0-3.0 of NaCl, and K2HPO41.0～2.0，KH2PO41.0～2.0，MgSO40.2～0.5，FeSO40.01～0.05，CoCl20.01～0.05，CaCl20.05-0.1, and natural pH.
(3) CCTCC No. M205115 fermentation medium containing inducer, the contents of each component are weight volume percentage, namely g/L: 10.0-20.0% of glucose, 3.0-5.0% of yeast extract, 2.0-5.0% of peptone, 1.0-3.5% of NaCl and K2HPO41.0～2.0，KH2PO41.0～2.0，MgSO40.2～0.5，FeSO40.01～0.05，CoCl20.01～0.05，CaCl20.01 to 0.06 percent, 1.0 to 2.0 percent of inducer, prepared by tap water, and the pH value is adjusted to 6.0 to 8.0 by 1.0mol of hydrochloric acid or NaOH solution. The inducer is selected from any one of 2, 2-dimethylcyclopropanecarbonitrile, 2-dimethylcyclopropanecarboxamide, acrylamide, caprolactam, acetamide and acrylonitrile.
(4) Preparing a CCTCC No. M205114 fermentation medium containing an activator, wherein the contents of all components are in percentage by weight and volume, namely g/L: 10.0-20.0 mannitol, 5.0-5.0 yeast extract, 2.0-5.0 peptone, 1.0-3.5 NaCl, K2HPO41.0～2.0，KH2PO41.0～2.0，MgSO40.2～0.5，FeSO40.01～0.05，CaCl20.01-0.06 wt%, 1.0-2.0 wt% of activator, prepared with tap water, and adjusting pH to 6.0-8.0 with 1.0mol of hydrochloric acid or NaOH solution. The activator is selected from any one of isobutyronitrile, caprolactam and 2, 2-dimethyl cyclopropane formamide.
The following examples were taken from any of the above ranges of components.
Example 1: isolation of nitrile hydratase-containing microorganisms
Adding 1g of soil sample and a proper amount of glass beads into 9ml of 0.9% physiological saline, and shaking uniformly to obtain a uniform soil suspension; 0.5ml of soil suspension is sucked and inoculated into a 250ml triangular flask filled with 30ml of enrichment medium, the flask is placed in a shaking table at 30 ℃ and 150rpm for 4 days, when the enrichment medium is turbid, 0.5ml of soil suspension is sucked and transferred into a fresh medium, and the culture is continued for 4 days; repeating the steps for 4-5 cycles, diluting the enrichment solution with multiple gradients, and coating the enrichment solution on a separation plate to obtain a single colony;
the enrichment medium uses 2, 2-dimethylcyclopropanecarbonitrile as a sole nitrogen source, and the composition and formula (g/L) of this example: na (Na)2HPO4·12H2O：2.5，KH2PO4：2，MgSO4·7H2O：0.5，FeSO4·7H2O：0.01，CoCl2：0.01，CaCl2: 0.06, 2, 2-dimethylcyclopropanecarbonitrile: 1.5, preparing the mixture by using tap water, and adjusting the pH value to 7.0;
inoculating the single colony to an enrichment medium, culturing for 48h and 72h, sampling, and detecting whether 2, 2-dimethylcyclopropanecarboxamide is generated or not by using a gas chromatography; the product with amide formation is the required microorganism Rhodococcus equi CCTCC No. M205115.
Example 2: isolation of optically selective amidase-containing microorganisms
The other steps were the same as in example 1 except that the nitrogen source in the enriched medium was changed to 2, 2-dimethylcyclopropanecarboxamide (1.5 g/L); detecting the corresponding body excess value (e.e value) of the product S- (+) -2, 2-dimethyl cyclopropane formamide by using chiral liquid chromatography, wherein the e.e value is more than 98 percent, and the product is the required microorganism Delftia tsuuhatensis CCTCC No. M205114.
Example 3: production of 2, 2-dimethylcyclopropanecarboxamide
The strain Rhodococcus equi CCTCC No. M205115 was put into a 250ml triangular flask containing 30ml of seed culture medium, the composition of which was as follows (g/L)): 10.0 percent of glucose, 5.0 percent of yeast extract, 2.0 percent of peptone, 1.0 percent of NaCl and K2HPO41.0，KH2PO41.0，MgSO40.2，FeSO40.01，CoCl20.01，CaCl20.05, natural pH (121 ℃, sterilization for 20min), culturing at 30 ℃ for 2 days to obtain seed liquid;
inoculating seed liquid to induction agent-containing caprolactamThe inoculation amount in the fermentation medium is 5% (V/V); the components of the fermentation medium are as follows (g/L): 10.0 percent of glucose, 5.0 percent of yeast extract, 2.0 percent of peptone, 1.0 percent of NaCl and K2HPO41.0，KH2PO41.0，MgSO40.2，FeSO40.01，CoCl20.01，CaCl20.05, 1.0 caprolactam, pH6.0 (sterilization for 20min at 121 ℃), fermentation culture for 60h at 20 ℃;
the fermentation liquor is centrifuged to obtain thalli, the thalli is washed by 0.9% physiological saline, the thalli is suspended in 10mM phosphate buffer (1000ml) to ensure that the pH value is 7.0 and the OD value of a buffer system is 1, 2-dimethylcyclopropanecarbonitrile is added to ensure that the concentration of a substrate is 0.95g/L, the thalli is converted for 0.5h in a water bath shaking table at the temperature of 30 ℃, gas chromatography detection shows that the substrate is completely converted, the thalli is centrifugally removed from the conversion liquor, and the supernatant is evaporated under reduced pressure, so 0.93g of the product 2, 2-dimethylcyclopropanecarboxamide is finally obtained, and the yield is 97.8%.
Example 4: production of 2, 2-dimethylcyclopropanecarboxamide
Seed solutions were prepared as in example 3;
inoculating the seed solution into an induction fermentation culture medium containing an inducer 2, 2-dimethylcyclopropanecarbonitrile, wherein the inoculation amount is 5% (V/V); the components of the fermentation medium are as follows (g/L): 10.0 percent of glucose, 5.0 percent of yeast extract, 2.0 percent of peptone, 1.0 percent of NaCl and K2HPO41.0，KH2PO41.0，MgSO40.2，FeSO40.01，CoCl20.01，CaCl20.05, 1.0 of 2, 2-dimethylcyclopropanecarbonitrile, pH 7.0 (sterilization is carried out for 20min at 121 ℃), the temperature is 30 ℃, and fermentation culture is carried out for 72 h;
after the cells were washed with 0.9% physiological saline, they were suspended in 50mM Tris-hydrochloric acid buffer (1000ml) so that the pH was 8.9 and the OD of the buffer system was 4, and 2, 2-dimethylcyclopropanecarbonitrile was added so that the concentration of the substrate was 4.75 g/L; transforming in a water bath shaker at 20 ℃ for 1.0h, and centrifuging to remove thalli; the conversion solution was evaporated under reduced pressure to give 4.55g of 2, 2-dimethylcyclopropanecarboxamide as a final product in a yield of 95.7%.
Example 5: production of 2, 2-dimethylcyclopropanecarboxamide
Seed solutions were prepared as in example 3;
inoculating the seed liquid into an induction fermentation culture medium containing an inducer acrylamide, wherein the inoculation amount is 5% (V/V); the components of the fermentation medium are as follows (g/L): 10.0 percent of glucose, 5.0 percent of yeast extract, 2.0 percent of peptone, 1.0 percent of NaCl and K2HPO41.0，KH2PO41.0，MgSO40.2，FeSO40.01，CoCl20.01，CaCl20.05, 1.0 acrylamide, pH 8.0 (sterilizing at 121 ℃ for 20min), temperature 40 ℃, fermenting and culturing for 80 h;
after the cells were washed with 0.9% physiological saline, they were suspended in 100mM citric acid buffer (1000ml) so that the pH was 6.0 and the OD value of the buffer system was 7, and 2, 2-dimethylcyclopropanecarbonitrile was added so that the substrate concentration was 19 g/L; transforming for 2.0h in a water bath shaker at 30 ℃, and centrifuging to remove thalli; the conversion solution was evaporated under reduced pressure to give 17.91g of 2, 2-dimethylcyclopropanecarboxamide as a final product in a yield of 94.2%.
Example 6: production of S- (+) -2, 2-dimethylcyclopropanecarboxamide
The slant activated strain Delftia tsuruhatensis CCTCC No. M205114 was placed in a 250ml flask containing 30ml of seed medium of the following composition (g/L): 10.0 parts of mannitol, 5.0 parts of yeast extract, 2.0 parts of peptone, 1.0 part of NaCl and K2HPO41.0，KH2PO41.0，MgSO40.2，FeSO40.01，CaCl20.05, natural pH (121 ℃, sterilization for 20min), and culturing at 30 ℃ for 48 h;
inoculating the seed liquid into a fermentation culture medium containing caprolactam as an activator, wherein the inoculation amount is 5% (V/V), and the fermentation culture medium comprises the following components (g/L): 10.0 parts of mannitol, 5.0 parts of yeast extract, 2.0 parts of peptone, 1.0 part of NaCl and K2HPO41.0，KH2PO41.0，MgSO40.2，FeSO40.01，CaCl20.05, 1.0 caprolactam, pH6.0 (sterilizing at 121 ℃ for 20min), fermenting and culturing for 80 h;
centrifuging the fermentation liquid to obtain thallus, washing with 0.9% physiological saline, suspending in 10mM phosphate buffer (1000ml) to make pH 7.0 and OD value of buffer system 5, adding racemic 2, 2-dimethylcyclopropanecarboxamide to make substrate concentration 1.14 g/L; converting for 4h in a water bath shaker at 20 ℃; centrifuging theconversion solution to remove thalli, adjusting the pH value of the supernatant to 12 by using sodium hydroxide, and extracting S- (+) -2, 2-dimethyl cyclopropane formamide (containing a small amount of 2, 2-dimethyl cyclopropane formamide) by using ethyl acetate with the same volume; distilling ethyl acetate under reduced pressure to obtain white powder; the white powder was dissolved in hot methanol for recrystallization to give 0.55g S- (+) -2, 2-dimethylcyclopropanecarboxamide in 48.2% yield with an e.e value greater than 98%.
Example 7: production of S- (+) -2, 2-dimethylcyclopropanecarboxamide
Seed solutions were prepared as in example 6;
inoculating the seed liquid into a fermentation culture medium containing isobutyronitrile as an activator, wherein the inoculation amount is 5% (V/V), and the fermentation culture medium comprises the following components (g/L): 10.0 parts of mannitol, 5.0 parts of yeast extract, 2.0 parts of peptone, 1.0 part of NaCl and K2HPO41.0，KH2PO41.0，MgSO40.2，FeSO40.01，CaCl20.05, isobutyronitrile at 1.0, pH 7.0 (sterilization at 121 ℃ for 20min), and fermentation culture for 72 h;
after the cells were washed with 0.9% physiological saline, they were suspended in 50mM Tris-hydrochloric acid buffer (1000ml) so that the pH was 8.9 and the OD of the buffer system was 10, and racemic 2, 2-dimethylcyclopropanecarboxamide was added so that the concentration of the substrate was 5.7 g/L; converting for 9h in a water bath shaker at 30 ℃; extracting with ethyl acetate, and recrystallizing to obtain 2.71g S- (+) -2, 2-dimethyl cyclopropane formamide with yield of 47.5% and e.e value greater than 98%.
Example 8: production of S- (+) -2, 2-dimethylcyclopropanecarboxamide
Seed solutions were prepared asin example 6;
inoculating the seed liquid into a fermentation medium containing 2, 2-dimethyl cyclopropane formamide serving as an activating agent, wherein the inoculation amount is 5% (V/V), and the fermentation medium comprises the following components (g/L): 10.0 parts of mannitol, 5.0 parts of yeast extract, 2.0 parts of peptone, 1.0 part of NaCl and K2HPO41.0，KH2PO41.0，MgSO40.2，FeSO40.01，CaCl20.05, 1.0 of 2, 2-dimethyl cyclopropane formamide, pH 8.0 (sterilization for 20min at 121 ℃), and fermentation culture for 60 h;
the cells were washed with 0.9% physiological saline, suspended in 100mM citric acid buffer (1000ml) so that the pH was 6.0 and the OD of the buffer system was 14, and racemic 2, 2-dimethylcyclopropanecarboxamide was added so that the substrate concentration was 22.8 g/L; converting for 13h in a water bath shaker at 40 ℃; extracting with ethyl acetate, and recrystallizing to obtain 5.52g S- (+) -2, 2-dimethyl cyclopropane formamide with yield of 48.2% and e.e value greater than 98%.
Example 9: combined conversion of racemic 2, 2-dimethylcyclopropanecarbonitrile to S- (+) -2, 2-dimethylcyclopropanecarboxamide with Rhodococcus equi CCTCC No. M205115 and Delftiatsurhautensis CCTCC No. M205114
Rhodococcus equi CCTCC No. M205115 for culturing the cells described in example 3;
the cell culture of Delftia tsuuhatensis CCTCC No. M205114 is described in example 6;
rhodococcus equi CCTCC No. M205115, after being washed with 0.9% physiological saline, suspended in 10mM phosphate buffer (1000ml) with OD of the buffer system of 4, 2-dimethylcyclopropanecarbonitrile was added to give a substrate concentration of 4.75 g/L; transforming in a water bath shaker at 30 ℃ for 1.0h, andcentrifuging to remove thalli; then, the bacterial cells of Delftia tsuruhatensis CCTCC No. M205114 washed by 0.9% physiological saline are added into the transformation liquid and transformed for 4h in a water bath shaker at 30 ℃; extracting with ethyl acetate, and recrystallizing to obtain 2.68g S- (+) -2, 2-dimethyl cyclopropane formamide with yield of 47% and e.e value greater than 98%.
Example 10: combined conversion of racemic 2, 2-dimethylcyclopropanecarbonitrile to S- (+) -2, 2-dimethylcyclopropanecarboxamide with Rhodococcus equi CCTCC No. M205115 and Delftiatsurhautensis CCTCC No. M205114
Rhodococcus equi CCTCC No. M205115 for culturing the cells described in example 3;
the cell culture of Delftia tsuuhatensis CCTCC No. M205114 is described in example 6;
rhodococcus equi CCTCC No. M205115, after being washed with 0.9% physiological saline, suspended in 50mM Tris-hydrochloric acid phosphate buffer (1000ml), the OD value of the buffer system being 8, 2-dimethylcyclopropanecarbonitrile was added to give a substrate concentration of 9.5 g/L; transforming for 2.0h in a water bath shaker at 30 ℃, and centrifuging to remove thalli; then, the bacterial cells of Delftia tsuruhatensis CCTCC No. M205114 washed by 0.9% physiological saline are added into the transformation liquid and transformed for 5h in a water bath shaker at 30 ℃; extracting with ethyl acetate, and recrystallizing to obtain 5.41g S- (+) -2, 2-dimethyl cyclopropane formamide with yield of 47.4% and e.e value greater than 98%.
Claims (4)
1. A two-step microorganism preparation method of S- (+) -2, 2-dimethyl cyclopropane formamide is characterized in that the microorganism is Rhodococcus equi (Rhodococcus equi) of Rhodococcus (Rhodococcus equi) screened from soil and sewage, CCTCC No. M205115 and Delftia tsuruhatensis bacteria of Delftia, CCTCC No. M205114, firstly, CCTCC No. M205115 is used for catalyzing racemic 2, 2-dimethyl cyclopropane carbonitrile to produce racemic 2, 2-dimethyl cyclopropane formamide, and then CCTCC No. M205114 is used for selectively hydrolyzing racemic 2, 2-dimethyl cyclopropane formamide to produce S- (+) -2, 2-dimethyl cyclopropane formamide; or the S- (+) -2, 2-dimethyl cyclopropane carboxamide is produced by jointly transforming racemic 2, 2-dimethyl cyclopropanecarbonitrile by using CCTCC No. M205115 and CCTCC No. M205114.
2. The preparation method of claim 1, wherein the CCTCC No. M205115 catalyzes racemic 2, 2-dimethylcyclopropanecarbonitrile to produce racemic 2, 2-dimethylcyclopropanecarboxamide, and the method comprises the following steps:
(1) preparing a seed culture medium, wherein the contents of all components are weight volume percent, g/L: 10.0-20.0% of glucose, 5.0-10.0% of yeast extract, 2.0-5.0% of peptone, 1.0-3.0% of NaCl and K2HPO41.0～2.0，KH2PO41.0～2.0，MgSO40.2～0.5，FeSO40.01～0.05，CoCl20.01～0.05，CaCl20.05-0.1, and natural pH;
(2) preparing a fermentation culture medium with CCTCC No. M205115 and an inducer, wherein the content of each component is weight volume percentage, g/L: 10.0-20.0% of glucose, 3.0-5.0% of yeast extract, 2.0-5.0% of peptone, 1.0-3.5% of NaCl and K2HPO41.0～2.0，KH2PO41.0～2.0，MgSO40.2～0.5，FeSO40.01～0.05，CoCl20.01～0.05，CaCl20.01-0.06 wt%, 1.0-2.0 wt% inducer, prepared with tap water, and adjusting pH to 6.0-8.0 with 1.0M hydrochloric acid or NaOH solution; the inducer is one of 2, 2-dimethylcyclopropanecarbonitrile, 2-dimethylcyclopropanecarboxamide, acrylamide, caprolactam, acetamide and acrylonitrile;
(3) preparing CCTCC No. M205115 thalli: inoculating the CCTCC No. M205115 activated by the inclined plane into a seed culture medium, wherein the culture conditions are as follows: culturing at the pH of 5.0-9.0 and the temperature of 20-50 ℃ for 24-48 h to obtain seed liquid; inoculating the seed liquid into a fermentation medium containing an inducer, wherein the culture conditions are as follows: performing induction culture for 60-80 h at the temperature of 20-40 ℃ and the initial pH of 6.0-8.0; centrifuging or filtering and collecting the induction culture solution to obtain thalli;
(4) biotransformation to prepare 2, 2-dimethylcyclopropanecarboxamide: washing the bacteria with 0.9% physiological saline, suspending the bacteria in phosphate buffer solution, Tris-hydrochloric acid buffer solution or citric acid buffer solution, wherein the pH of the buffer solution is 6.5-9.0, adding a substrate 2, 2-dimethylcyclopropanecarbonitrile, and the concentration of the substrate is 0.8-20 in g/L; the conversion temperature is 20-40 ℃, and the time is 0.5-4 h;
(5) extraction of 2, 2-dimethylcyclopropanecarboxamide: the conversion solution is centrifuged to remove thalli, and the supernatant is evaporated under reduced pressure to obtain the product 2, 2-dimethyl cyclopropane formamide.
3. The preparation method of claim 1, wherein the CCTCC No. M205114 selectively hydrolyzes racemic 2, 2-dimethylcyclopropanecarboxamide to produce S- (+) -2, 2-dimethylcyclopropanecarboxamide, and the method comprises the following steps:
(1) preparing a seed culture medium, wherein the contents of all components are weight volume percent, g/L: 10.0-20.0% of glucose, 5.0-10.0% of yeast extract, 2.0-5.0% of peptone, 1.0-3.0% of NaCl and K2HPO41.0～2.0，KH2PO41.0～2.0，MgSO40.2～0.5，FeSO40.01～0.05，CoCl20.01～0.05，CaCl20.05-0.1, and natural pH;
(2) preparing a CCTCC No. M205114 fermentation medium containing an activator, wherein the contents of all components are weight volume percent, g/L: 10.0-20.0 mannitol, 5.0-5.0 yeast extract, 2.0-5.0 peptone, 1.0-3.5 NaCl, K2HPO41.0～2.0，KH2PO41.0～2.0，MgSO40.2～0.5，FeSO40.01～0.05，CaCl20.01-0.06 wt%, 1.0-2.0 wt% of activator, prepared with tap water, and adjusting pH to 6.0-8.0 with 1.0M hydrochloric acid or NaOH solution; the activating agent is one of caprolactam, isobutyronitrile and 2, 2-dimethyl cyclopropane formamide;
(3) preparation of CCTCC No. M205114 thalli: inoculating the CCTCC No. M205114 activated by the inclined plane into a seed culture medium, wherein the culture conditions are as follows: culturing at the pH of 6.0-8.0 and the temperature of 20-40 ℃ for 24-48 h to obtain seed liquid; inoculating the seed liquid into a fermentation culture medium, wherein the culture conditions are as follows: culturing for 60-80 h at 20-40 ℃ and initial pH of 6.0-8.0; centrifuging or filtering and collecting the induction culture solution to obtain thalli;
(4) biotransformation of S- (+) -2, 2-dimethylcyclopropanecarboxamide: washing the above-mentioned fungus body with 0.9% physiological saline, suspending in phosphate buffer solution, or Tris-hydrochloric acid buffer solution, or citric acid buffer solution, the pH of buffer solution is 6.5-9.0, adding racemic 2, 2-dimethyl cyclopropane formamide, the concentration of substrate 2, 2-dimethyl cyclopropane formamide is expressed by g/L as 1.14-22.8; the conversion temperature is 20-40 ℃, and the time is 4-13 h;
(5) extracting S- (+) -2, 2-dimethyl cyclopropane formamide: centrifuging the conversion solution to remove thalli, adjusting the pH value to 12 by using sodium hydroxide, extracting by using ethyl acetate with the same volume, distilling under reduced pressure, and recrystallizing by using methanol to obtain the S- (+) -2, 2-dimethyl cyclopropane formamide.
4. The preparation method of claim 1, 2 or 3, wherein the CCTCC No. M205115 and the CCTCC No. M205114 are used for jointly converting racemic 2, 2-dimethylcyclopropanecarbonitrile to produce S- (+) -2, 2-dimethylcyclopropanecarboxamide, and the method comprises the following steps:
(1) washing the prepared CCTCC No. M205115 strain with 0.9% physiological saline, suspending the strain in phosphate buffer solution, Tris-hydrochloric acid buffer solution or citric acid buffer solution, wherein the pH of the buffer solution is 6.5-9.0, adding a substrate 2, 2-dimethylcyclopropanecarbonitrile, and the concentration of the substrate is expressed by g/L as 4.75-9.5; the conversion temperature is 20-40 ℃, and the time is 0.5-4 h; centrifuging to remove thallus;
(2) washing the prepared CCTCC No. M205114 strain with 0.9% physiological saline, adding the strain-removed strain-containing conversion solution containing 2, 2-dimethylcyclopropanecarboxamide, and continuing to convert for 4-6 h at the conversion temperature of 20-40 ℃;
(3) and extracting the conversion solution by ethyl acetate, and recrystallizing to obtain the S- (+) -2, 2-dimethyl cyclopropane carboxamide.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100616809A CN100345974C (en) | 2005-11-24 | 2005-11-24 | Microbiological preparation method of S-(+)-2,2-dimethyl cyclo propyl formamide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100616809A CN100345974C (en) | 2005-11-24 | 2005-11-24 | Microbiological preparation method of S-(+)-2,2-dimethyl cyclo propyl formamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1786179A CN1786179A (en) | 2006-06-14 |
| CN100345974C true CN100345974C (en) | 2007-10-31 |
Family
ID=36783792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100616809A Active CN100345974C (en) | 2005-11-24 | 2005-11-24 | Microbiological preparation method of S-(+)-2,2-dimethyl cyclo propyl formamide |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100345974C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100547067C (en) * | 2007-08-10 | 2009-10-07 | 浙江工业大学 | Brevibacterium epidermidis ZJB-07021 and the preparation (S)-2, the application in the 2-dimethyl-cyclopropane carboxamide |
| CN100593569C (en) * | 2007-11-28 | 2010-03-10 | 浙江工业大学 | Bacillus cercus and chiral 2,2-dimethyl cyclopropanecarboxylic acid/cyclopropancarboxamid prepared from the same |
| CN101445466B (en) * | 2008-12-25 | 2012-05-16 | 浙江工业大学 | Method for purifying 2, 2-dimethyl-cyclopropane carboxamide produced by biocatalytic method |
| CN102250934A (en) * | 2010-05-17 | 2011-11-23 | 浙江海正药业股份有限公司 | High-efficient expression and application of amidohydrolase |
| CN102161978B (en) * | 2011-01-25 | 2012-08-08 | 浙江工业大学 | Rhodococcus ZJPH1003 and application thereof in preparing S-(+)-2,2-dimethylcyclopropane carboxylic acid |
| CN104293752B (en) * | 2014-09-19 | 2017-07-28 | 浙江工业大学 | Recombinant amidase Dt Ami 2, encoding gene, carrier, engineering bacteria and application |
| CN104293753B (en) * | 2014-09-19 | 2017-07-25 | 浙江工业大学 | Recombinant amidase Dt Ami 7, encoding gene, carrier, engineering bacteria and application |
| CN114196659B (en) * | 2021-12-09 | 2024-02-13 | 浙江工业大学 | Amidase mutant, coding gene, engineering bacteria and application thereof |
| CN114703110B (en) * | 2022-05-10 | 2024-01-26 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | Culture medium and method for inducing acetic acid bacteria to enter VBNC state |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN86100062A (en) * | 1985-01-08 | 1986-10-01 | 日东化学工业株式会社 | Utilize microorganism to prepare the method for acid amides |
| US5273903A (en) * | 1991-03-06 | 1993-12-28 | Lonza Ltd. | Biotechnological process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide |
| CN1384096A (en) * | 2002-05-31 | 2002-12-11 | 中国科学院上海有机化学研究所 | Chiral propanamide and propionic acid compounds, their biocatalytic synthesis and use |
-
2005
- 2005-11-24 CN CNB2005100616809A patent/CN100345974C/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN86100062A (en) * | 1985-01-08 | 1986-10-01 | 日东化学工业株式会社 | Utilize microorganism to prepare the method for acid amides |
| US5273903A (en) * | 1991-03-06 | 1993-12-28 | Lonza Ltd. | Biotechnological process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide |
| CN1384096A (en) * | 2002-05-31 | 2002-12-11 | 中国科学院上海有机化学研究所 | Chiral propanamide and propionic acid compounds, their biocatalytic synthesis and use |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1786179A (en) | 2006-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100345974C (en) | Microbiological preparation method of S-(+)-2,2-dimethyl cyclo propyl formamide | |
| JP6720420B2 (en) | Use in the preparation of (S)-α-ethyl-2-oxo-1-pyrrolidine acetate by methylopira and its selective resolution | |
| CN1010104B (en) | Process for preparation of amides using microorganisms | |
| CN101113423B (en) | Microbacterium and method for producing chirality pharmaceutical intermediate compound by using the bacterial conversion | |
| CN1044005C (en) | Process for production of amide compounds and microorganisms for use therein | |
| JP2005516612A (en) | Process for producing 2-hydroxyisobutyric acid and methacrylic acid from acetone cyanohydrin | |
| WO2007026860A1 (en) | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE α-HYDROXYCARBOXYLIC ACID | |
| CN108410749B (en) | Method for preparing (-) gamma-lactam by asymmetric hydrolysis of marine low-temperature (+) gamma-lactamase | |
| CN101260415A (en) | Preparation of two kinds of high optical activity enantiomer of ethyl 4-cyano-3-hydroxybutyrate by biological catalysis method | |
| IE74179B1 (en) | Biotechnological process for the production of S- (+) -2,2-dimethylcyclopropanecarboxamide and R- (-) -2,2-dimethylcylopropanecarboxylic acid | |
| JP2010532992A (en) | Microbial kinetic resolution of ethyl 3,4-epoxybutyrate | |
| EP0745681B1 (en) | Optical resolution of chlorohydrin with microorganism | |
| CN1961067A (en) | Method for culturing the nitrile hydratase-producing strain rodococcus rhodochrous M33 | |
| CN1408848A (en) | Immobile bacillus and method for resolving and preparing chiral cyclopentenylone using said bacillus | |
| CN1644012A (en) | Serration and its use in preparation of chiral precurser for dielzepin | |
| JPH04234991A (en) | New microorganism | |
| JP3705046B2 (en) | Preparation of optically active 4-halogeno-1,3-butanediol and its derivatives by microorganisms | |
| CN103834600A (en) | Fermentation method of photosensitive nitrile hydratase bacterial strain for catalyzed synthesis of acrylamide | |
| JP3123428B2 (en) | Optical resolution of chlorohydrin by microorganisms | |
| CN1254760A (en) | Microbe process for preparing (4R, 6R)-4-hydroxyl-2,2,6-trimethyl cyclohexanone | |
| CN114134057B (en) | Saccharomyces cerevisiae SWGCJM001 and culture method and application thereof | |
| JP3659123B2 (en) | Method for optical resolution of 4-halogeno-3-alkanoyloxybutyronitrile | |
| CN111534472B (en) | Bacillus aryabhattai WZZ10 and application thereof in chiral resolution of 2-tetrahydrofurfuryl acid | |
| KR20050072066A (en) | Method for producing optically active 3-chloro-2-methyl-1,2-propanediol taking advantage of microorganism | |
| JP3088205B2 (en) | Method for producing optically active 1,3-butanediol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Effective date: 20120712 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20120712 Address after: Hangzhou City, Zhejiang province 310014 City Zhaohui District Six Co-patentee after: Zhejiang Hisun Pharmaceutical Co., Ltd. Patentee after: Zhejiang University of Technology Address before: Hangzhou City, Zhejiang province 310014 six Zhaohui District of Zhejiang University of Technology Patentee before: Zhejiang University of Technology |